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Different brain responses 
to electro-acupuncture and 
moxibustion treatment in patients 
with Crohn’s disease
Chunhui Bao1,*, Peng Liu2,*, Huirong Liu3,*, Xiaoming Jin4, Vince D. Calhoun5,6, Luyi Wu1, 
Yin Shi3, Jianye Zhang7, Xiaoqing Zeng8, Lili Ma9, Wei Qin2, Jingzhi Zhang1, Xiaoming Liu2, 
Jie Tian2 & Huangan Wu1
This study aimed to investigate changes in resting state brain activity in remissive Crohn’s Disease (CD) 
patients after electro-acupuncture or moxibustion treatment. Fifty-two CD patients and 36 healthy 
subjects were enrolled, and 36 patients were equally and randomly assigned to receive either electro-
acupuncture or moxibustion treatment for twelve weeks. We used resting state functional magnetic 
resonance imaging to assess Regional Homogeneity (ReHo) levels, and Crohn’s Disease Activity Index 
(CDAI) and Inflammatory Bowel Disease Questionnaire (IBDQ) scores to evaluate disease severity and 
quality of life. The results show that (i) The ReHo levels in CD patients were significantly increased in 
cortical but decreased in subcortical areas, and the coupling between them was declined. (ii) Both 
treatments decreased CDAI, increased IBDQ scores, and normalized the ReHo values of the cortical 
and subcortical regions. (iii) ReHo changes in multiple cortical regions were significantly correlated 
with CDAI score decreases. ReHo changes in several subcortical regions in the electro-acupuncture 
group, and those of several cortical regions in the moxibustion group, were correlated with reduced 
CDAI. These findings suggest that both treatments improved cortex-subcortical coupling in remissive 
CD patients, but electro-acupuncture regulated homeostatic afferent processing network, while 
moxibustion mainly regulated the default mode network of the brain.
Crohn’s disease (CD) is a type of chronic inflammatory bowel disease (IBD). It can affect any area of the gastro-
intestinal tract, and causes main symptoms including persistent diarrhea, abdominal pain, as well as weight loss1. 
With young adults being the most prevalent demographic group with CD, this disease may impair their quality 
of life as well as economic well-being2,3.
Despite the high prevalence rate of Crohn’s disease, the treatment for CD is far from satisfactory4,5. 
Pharmacological treatment can induce the remission of CD symptoms, but the side effects of prolonged drug 
use limit its efficacy as a long-term treatment solution5,6. As an important part of Traditional Chinese Medicine, 
acupuncture and moxibustion are used in China and many other countries of the world. They are used for the 
treatment of a variety of gastrointestinal diseases including IBD7–11. Although randomized controlled trials10,11 
have demonstrated that patients with CD benefit from acupuncture and moxibustion treatment, the underlying 
mechanisms of these treatments are unclear.
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Recent researches have indicated that regions of the central nervous system involved in the brain-gut axis dys-
function may play an important role in the development and mechanism of IBD, and those abnormal changes in 
the structure and function of the brain might be directly involved in development of IBD12–17. Earlier studies have 
also confirmed that clinical efficacy of acupuncture relies on the mediation of the central nervous system18–20. 
Electro-acupuncture is a modern method developed from Chinese traditional acupuncture, which relies on manual 
manipulation of needles. Electro-acupuncture delivers electrical pulses to needles for increasing stimulation to 
acupuncture points and improving its clinical effect. Moxibustion is a treatment method that uses the heat from 
moxa burning to stimulate acupuncture points. It has been shown to have effects similar to acupuncture in clinical 
practice, but is less used and studied. Herb-partition moxibustion is a type of moxibustion that involves igniting 
a moxa cone on an herbal cake placed on an acupuncture point. Although electro-acupuncture and moxibustion 
are different in their stimulation, they are believed to generate similar clinical outcomes. Earlier research showed 
that electro-acupuncture normalizes brain’s functional activity21,22, but data on the mechanism of moxibustion is 
scarce. It remains an open question whether these treatment methods induce different responses in the brain and 
whether their clinical efficacy is linked to the normalization of the brain’s functional activity.
Resting state-functional magnetic resonance imaging (rs-fMRI) reveals brain’s functional activities and organ-
ization without external stimulation, which provides a useful tool for studying the mechanisms of acupuncture on 
the central nervous system. As a new analytical method, regional homogeneity (ReHo) can reflect abnormalities 
in the synchronization and coordination of spontaneous neuronal activity of brain regions and reveals brain’s 
pathophysiological changes23. Using rs-fMRI technique and ReHo analysis, the present study aimed to compare 
the effects of electro-acupuncture and moxibustion on brain activities of CD patients in remission. We hypoth-
esized that electro-acupuncture and moxibustion have a regulatory effect on the abnormal brain activities at 
resting state, evoking similar and different responses from the brain. Specifically, we compared the resting-state 
brain activities between CD patients in remission and healthy controls (HCs), and investigated the effects of 
electro-acupuncture and moxibustion on brain activities of CD patients and potential correlations between brain 
activity changes and clinical outcomes.
Methods
Participants. Patients with CD: A total of 52 patients with CD were recruited from the Specialist Outpatient 
Clinic for Inflammatory Bowel Disease at the Shanghai Research Institute of Acupuncture and Meridian and the 
Endoscopy Center of the Zhongshan Hospital affiliated with Fudan University. The patients were subjected to 
systemic and gastrointestinal screening, which included colonoscopy and pathological biopsy. In addition, their 
C-reactive protein, erythrocyte sedimentation rate and platelet counts were also measured and recorded two 
weeks prior to fMRI scans. The colon screening was conducted one month prior to the fMRI scans by an experi-
enced endoscopist from the Zhongshan Hospital who was blind to the experimental conditions. The screening 
was scored based on the Crohn’s disease endoscopic index of severity (CDEIS).
Inclusion criteria: (1) 18–50 years old; (2) more than 6 years of education; (3) remission period lasting 
12 months or longer; (4) CDAI score ≤ 150; (5) CDEIS score < 3; (6) dominant right hand; (7) no acupuncture 
treatment in the last three months. Exclusion criteria: (1) C reactive protein > 10 mg/L; erythrocyte sedimenta-
tion rate > 20 mm/h; platelets > 300 × 109/L; (2) CD patients who suffered from abdominal fistula, sinus or had 
CD-related abdominal surgery; (3) patients who received glucocorticoids, anti TNF-α drugs or other biological 
agents, mental or opioid drugs in the past 3 months; (4) pregnant or lactating women; (5) patients with current 
or previous history of mental and nervous system disease or head trauma and loss of consciousness; (6) claustro-
phobic patients, and (7) those with metal implants in the body.
Subjects who received electro-acupuncture or moxibustion treatment also needed to exclude the one who taking 
immunosuppressive drugs in the past 3 months, because immunosuppressive drugs are suggested to against the 
effect of acupuncture and moxibustion treatment, most acupuncture studies in the treatment of IBD always rule 
out such patients8,10,11. Twelve patients excluded for taking azathioprine, and 4 cases refused to receive acupunc-
ture or moxibustion treatment, only accept fMRI scan once. Finally, 36 subjects were enrolled to receive acupunc-
ture or moxibustion intervention. There are no patients had smoking habit.
HCs: 36 right-handed, healthy volunteers were recruited via a newspaper advertisement by the Shanghai 
University of Traditional Chinese Medicine. They did not receive any medications, and had no gastrointestinal 
symptoms or had negative test results on colon assessments done within the preceding year.
All participants were evaluated by an experienced gastrointestinal expert from the Zhongshan Hospital of 
Fudan University. To rule out anyone with psychiatric disorders, mental examinations were conducted by a spe-
cialist from the Shanghai Mental Health Center, based on a structured psychiatric interview from the Diagnostic 
and Statistical Manual of Mental Disorders, 4th edition (DSM-IV).
Two weeks after the baseline period, 36 patients who were willing to receive acupuncture and moxibustion 
treatment were equally and randomly assigned to either the electro-acupuncture group (EA group) or the moxi-
bustion group (Mox group). The process of random assignment was blind, serially-coded, and confidential. The 
different groups of CD patients were assigned to different isolated rooms for treatment and were blind to the setup 
of the study.
The present study complies with the Declaration of Helsinki (Edinburgh version, 2000). The study was 
approved by the Institutional Review Board of the Yueyang Hospital of Integrated Chinese and Western Medicine 
affiliated with the Shanghai University of Traditional Chinese Medicine. All study participants signed informed 
consent forms. The present research has been registered in the Clinical Trials database (NCT01696838, https://
clinicaltrials.gov/) on September 25th, 2012.
Electro-acupuncture and moxibustion treatments. Each group received treatment three times a 
week for 12 weeks, totaling up to 36 treatment sessions. The acupuncture points for both groups were chosen 
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in reference to prior research10, typical for the treatment of gastrointestinal diseases: ST25 (both sides), CV6 
andRN12 (Fig. 1).
Electro-acupuncture group. After conventional disinfection with iodine and alcohol, 0.30 × 40 mm nee-
dles (Hwato, Suzhou, China) were inserted 20–25 mm beneath the skin and then connected to a HANS 
electro-acupuncture apparatus (Model LH100A TENS, Nanjing, China). The two conducting ends of the 
electro-needles were respectively connected to the ST25 and CV6 at the left-hand side, as well as the ST25 and 
RN12 at the right-hand side. Pulsed stimulus was delivered at a rate of 2/100 Hz and intensity of 1–2 mA for 
30 minutes.
Moxibustion group. Radix aconiti preparata, Coptis chinesis, Aucklandia Lappa, Carthamus tinctorius, Salvia 
miltiorrhiza and Angelica sinensis were ground into fine power and passed through a 100 mesh sieve. The resulting 
2.8 g medicinal powder was dissolved in lukewarm water with malt sugar to form a paste. With the use of a mold, 
the mixture was shaped into an herbal cake with a 23 mm diameter and 5 mm thickness. Moxa cone, with a height 
of 16 mm and a diameter of 18 mm (“Han Medicine”, Nanyang, China), was placed on top of the herbal cake and 
ignited for herbs-partitioned moxibustion on each acupuncture point every time.
The dosage remained constant for CD patients who were also receiving mesalazine treatment.
Outcome measurement. The Crohn’s Disease Activity Index (CDAI)24 served as the indication of primary 
treatment efficacy. CDAI is validated as a measure of CD and treatment efficacy. CDAI < 150 was classified as the 
remission stage while > 150 was classified as the active stage. Participants were assessed at two time points at day 
0 and twelve weeks after enrollment in the study.
The Inflammatory Bowel Disease Questionnaire (IBDQ)25 was used to assess the quality of life of CD patients. 
The IBDQ has been validated as an effective measure of health-related quality of life (HRQoL) for adult IBD 
patients. It consists of 32 questions, each on a 7-point Likert scale, with a total score between 32 and 224. A higher 
score on the IBDQ indicates a better quality of life. Participants were also assessed at two time points, at day 0 and 
twelve weeks after enrollment in the study.
Resting-state fMRI scan. The fMRI data were acquired in an interleaved, multi-slice mode using a 
SIEMENS TRIO 3T clinical scanner (Magnetom Verio, Siemens, Germany) in the Department of Radiology 
at the Shanghai Mental Health Center. During the fMRI examination, all patients and HCs were instructed to 
relax with their eyes closed but not to fall asleep and not to think of anything in particular. They were placed 
in supine position with the head snugly fixed by a custom-built head holder to minimize head motion, and a 
pair of foam pads to minimize noise. Functional images were collected with an echo-planar imaging sequence 
(TR/TE: 2000 ms/30 ms, flip angle = 90°, field of view: 240 mm × 240 mm, matrix size: 240 × 240, in-plane res-
olution: 1 mm × 1 mm, slice thickness was 5 mm with no gaps, 32 slices). Using a simple questionnaire after the 
scan, we confirmed that no participants fell asleep during data acquisition. All participants completed the image 
acquisition procedure.
Imaging data processing. All of the fMRI data included the 6 min-resting data from HCs and the 
6 min-resting data from patients at baseline, as well as the 6 min-resting data from patients at the end of 
electro-acupuncture or moxibustion treatment. All imaging data were preprocessed using the same procedure.
The resting-state fMRI data were pre-processed using the SPM8 software package (http://www.fil.ion.ucl.
ac.uk/spm/software/spm8). The first five images of each functional time series were discarded for longitudinal 
magnetization to reach the equilibrium. All slices of the remaining images were processed by slice-timing adjust-
ment, and realigned to the first volume. Then, the time series of images of each subject were motion-corrected; the 
head motion parameters were obtained by estimating six parameters capturing translation in each direction and 
Figure 1. Schematic diagrams show the methods of electro-acupuncture and moxibustion treatments and 
the locations of acupoints used in this study. The acupoints were ST25 (Tianshu), RN6 (Qihai) and RN12 
(Zhongwan).
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angular rotation, relative to the first volume. The data set in which the translation or rotation parameters exceeded 
1.5 mm or 1.5 degrees of rotation were discarded. The realigned functional images were then spatially normalized 
to the Montreal Neurologic Institute (MNI) space, using the normalization parameters estimated by the T1 struc-
tural image unified segmentation, re-sampled to 3 mm voxels. In order to conserve the fine-grained local pattern 
and to avoid artificial connections, smoothing was not applied to normalized data. Several sources of spurious 
variance, including estimated motion parameters, linear drift, and average blood oxygen level-dependent (BOLD) 
signals in ventricular and white matter regions, were removed from the data using linear regression. Temporal 
bandpass filtrating (0.01–0.08 Hz) was performed to reduce the effect of low-frequency drifts and high-frequency 
noise26. All of these procedures were performed using the DPARSF software (http://www.restfmri.net/forum/
DPARSF)27.
ReHo analysis. Individual ReHo maps were generated by calculating the Kendall’s coefficient of concordance 
(KCC)28, and were used to measure the correlation of the time series of a given voxel with the time series of its 26 
nearest neighbors, within a gray matter mask in a voxel-wise manner using the REST software (http://restfmri.
net/forum/index.php)27. When the center cube was on the edge of the gray matter mask, we only calculated ReHo 
for a voxel if all of remaining nearby voxels were within the gray matter mask. For each participant, the KCC 
map was normalized by dividing the KCC in each voxel by the mean KCC of the total gray matter using DPARSF 
software.
Statistical analysis. Clinical variables. Statistical analyses were performed by two blind evaluators using 
SPSS 16.0 (SPSS Inc., Chicago, IL, USA). The data analysis was based on an intention-to-treat population. 
Two independent samples t-test was used for normally distributed continuous variables. Nonparametric tests 
(Kruskal-Wallis test) were used for between-group comparisons of abnormally distributed continuous varia-
bles. Pearson’s χ 2 test or Fisher’s exact test was used for between-group comparisons of categorical variables. All 
P values were two-sided and P < 0.05 was considered statistically significant.
Imaging data. Analysis between the CD patients and HCs: at the second level of analysis, a two-sample test was 
initially applied to investigate the differences in patients compared to the whole brain ReHo values of HCs, with 
age, weight and gender as covariates. The statistical threshold was set at P < 0.05 (false discovery rate (FDR) cor-
rected) and the cluster size exceeded five.
Analysis of electro-acupuncture and moxibustion treatment: paired t-test was then used to compare the whole 
brain ReHo values before and after electro-acupuncture or moxibustion treatment in different groups. The statis-
tical threshold was also set at P < 0.05 (FDR corrected), and the cluster size exceeded five. Age, weight and gender 
were treated as insignificant covariates.
Based on the brain regions showing differences in ReHo values after electro-acupuncture or moxibustion 
treatment in the paired t-test, regions of interest (ROIs) were selected from the sets of voxels within 6-mm 
spheres with centers at the peak of the clusters. Pearson’s correlation analysis was applied to detect the relation-
ship between the mean change in ReHo values (post-treatment minus baseline) in each ROI and the changes in 
CDAI scores for CD patients with age, gender and weight as covariates. The significance level was set at P < 0.05. 
Bonferroni corrected for multiple comparisons.
All ReHo-related maps were superimposed on a template provided by the MRIcroN software (http://www.
cabiatl.com/mricro/) for display and brain regions showing differences were presented in MNI coordinates.
Results
Differences between CD patients and HCs. Clinical variables. Clinical and demographic characteristics 
of all study subjects are shown in Table 1. The demographic characteristics of CD patients and HCs, including 
gender, age, height and weight, were not significantly different (P > 0.05) (Table 1).
Increased ReHo value in CD. In comparison with the HCs, the ReHo values of CD patients were significantly 
greater in the bilateral ACC, superior frontal medial cortex, middle frontal cortex, superior temporal pole, precu-
neus, right superior frontal cortex, inferior temporal cortex, angular gyrus, left middle temporal cortex, superior 
parietal cortex and middle occipital cortex (P < 0.05, corrected) (Table 2, Fig. 2a).
Decreased ReHo value in CD. In comparison with the HCs, the ReHo values of CD patients were significantly 
lower in the bilateral thalamus, insula, MCC, PCC, lingual gyrus, cerebellum, PAG, brainstem, left HIPP, SMA, 
postcentral gyrus, inferior frontal operculum cortex, right amygdala and superior temporal cortex (P < 0.05, 
corrected) (Table 2, Fig. 2b).
Differences after electro-acupuncture and moxibustion treatment. All 18 patients of the moxi-
bustion group underwent fMRI scans after treatment, which returned useful results. In the electro-acupuncture 
group, one patient demonstrated head movements during the scan, while another was unable to complete 
the scans due to schedule conflicts. Ultimately, the fMRI data of the remaining 16 patients were included and 
analyzed.
Clinical variables. The electro-acupuncture and moxibustion groups exhibited no significant differences in age, 
gender, height, weight, disease course, combination medication as well as CDAI and IBDQ scores (P > 0.05) 
(Table 3).
The CDAI scores of the two groups were significantly lower after treatment (P < 0.001, P < 0.001), while the 
IBDQ scores increased significantly (P < 0.01, P < 0.01). The two treatment groups had no significant difference 
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(from baseline to post-treatment) in the CDAI and IBDQ scores (P > 0.05, P > 0.05). The reduced CDAI scores 
and elevated the IBDQ scores in patients of both electro-acupuncture and moxibustion groups suggest that both 
treatments improved the disease condition and quality of life (Table 4).
Changes in ReHo value after electro-acupuncture and moxibustion treatment. In the electro-acupuncture group, 
there were significant increases in the ReHo values in the bilateral MCC, thalamus, the HIPP, the inferior frontal 
cortex, the precentral cortex, the paracentral lobule and the superior temporal cortex, the left paraHIPP, the pal-
lidum and cerebellum, the right insula, the putamen, the postcentral cortex, the SMA, the lingual cortex and the 
brainstem. There were significant decreases in the ReHo values in the bilateral ACC, the orbital frontal cortex, the 
inferior temporal cortex, the temporal pole and the middle occipital cortex, the left superior parietal cortex, the 
angular cortex and the cuneus, the right middle frontal cortex and the caudate nucleus (P < 0.05, FDR corrected) 
(Table 5).
In the moxibustion group, significant increases in the ReHo value were observed after treatment in the bilateral 
MCC, pallidum, putamen, inferior frontal cortex, SMA, middle occipital cortex, cerebellum and brainstem, left 
PCC, paraHIPP/HIPP, paracentral lobule, angular cortex and fusiform cortex, right insula, precentral cortex and 
postcentral cortex. Significant decreases in the ReHo value were also detected in the bilateral middle temporal 
cortex and lingual cortex, left superior medial frontal cortex, inferior temporal cortex and temporal pole, right 
orbital frontal cortex, middle frontal cortex and the caudate nucleus (P < 0.05, FDR corrected) (Table 5).
Correlation analysis of brain responses and clinical variables. In the electro-acupuncture group, the decrease in 
the CDAI score was significantly positively correlated with the decreases in the ReHo value in the ACC, the dor-
solateral prefrontal cortex (dlPFC) and the temporal pole, and was negatively correlated with the increases in the 
ReHo value in the MCC, the thalamus, insula, the HIPP, the precentral and the postcentral cortex and SMA after 
treatment (P < 0.05, Bonferroni corrected) (Fig. 3a).
In the moxibustion group, the decrease in the CDAI score was significantly positively correlated with the 
decreases in the ReHo value in the dlPFC, the dorsomedial prefrontal cortex (dmPFC) and the temporal pole, and 
was negatively correlated with the increases in the ReHo value in the MCC, the PCC, the precentral and postcen-
tral cortex and the SMA after treatment (P < 0.05, Bonferroni corrected) (Fig. 3a).
CD (n = 52) HCs (n = 36) P value
Gender (male/female), n 37/15 24/12 0.65
Age (years), mean + SD 30.85 ± 7.60 30.33 ± 5.75 0.73
Height (cm), mean + SD 170.15 ± 6.96 169.47 ± 7.17 0.66
Weight (kg), mean + SD 56.85 ± 9.27 59.58 ± 6.49 0.13
Disease duration (years), mean + SD 6.30 ± 4.07 — —
CDAI, mean + SD 71.22 ± 42.03 — —
IBDQ, mean + SD 174.23 ± 26.98 — —
Platelet▽, mean + SD 218.79 ± 44.72 — —
Erythrocyte sedimentation rate△, mean + SD 11.46 ± 5.53 — —
C, reactive protein▼, mean + SD 5.01 ± 5.86 — —
CDEIS, mean + SD 1.05 ± 0.69 — —
Montreal classification
Age at diagnosis A1 4 — —
A2 46 — —
A3 2 — —
Location L1 10 — —
L2 12 — —
L3 30 — —
L4 0 — —
Behavior B1 17 — —
B2 3 — —
B3 14 — —
B1P 5 — —
B2P 1 — —
B3P 12 — —
Concomitant medication
Mesalazine 37 — —
Azathioprine 12 — —
Table 1.  Demographic and clinical characteristics of CD patients and HCs. ▽Normal range:  
100–300 × 109/L; △Normal range: 0–20 mm/h; ▼Normal range: 0–10 mg/L.
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Similar and different responses of brain regions after electro-acupuncture and moxibustion treatments. 
Electro-acupuncture and moxibustion caused similar activities of left MCC, SMA, right precental cortex, post-
central cortex, dlPFC and temporal pole (Fig. 3b). Additionally, electro-acupuncture caused activities of bilat-
eral thalamus, left HIPP and right insula and ACC, while moxibustion caused activities of left mPFC and PCC 
(Fig. 3c).
Discussion
In this study, we examined and compared, for the first time, the effects of electro-acupuncture and moxibustion 
treatments in regulating brain functional activities in CD patients at resting state. We found that ReHo levels in 
various brain regions were significantly increased or decreased in CD patients in comparison with HCs, and that 
the abnormal ReHo values in multiple brain regions were reversed after electro-acupuncture or moxibustion 
treatments. We also showed that electro-acupuncture and moxibustion treatments have comparable clinical effi-
cacy on improving symptoms of CD, but their effects on functional brain activity includes common and unique 
brain regions.
Differences in brain activities in the resting state between CD patients and HCs. In comparison 
with HCs, the patients with CD exhibited abnormal fluctuations in the ReHo levels in different brain regions. 
These brain regions were involved in pain, emotion, cognition, attention, as well as homeostasis. The insula, ACC 
and thalamus are important components of the homeostatic afferent processing network, which is consistently 
activated in response to homeostatic afferent fiber activation from non-painful and painful visceral and somatic 
stimuli, as well as emotional stimuli29. Abnormal ReHo fluctuations in these brain regions in CD patients indicate 
Regions Hem BA
MNI
t value VoxelsX Y Z
CD < HC
 Insula L 48 − 35 − 30 21 − 4.77 72
 MCC
L 23 − 2 − 22 46 − 3.91 19
R 23 1 − 18 49 − 3.25 11
 PCC L 23 − 1 − 31 37 − 3.21 12
 Thalamus
L — − 18 − 16 9 − 3.77 37
R — 12 − 16 12 − 3.78 42
 Amygdala R 36 33 1 − 20 − 3.41 5
 SMA
L 6/8 − 2 6 57 − 3.47 34
R 6 2 4 60 − 3.23 29
 Inferior frontal cortex L 48 − 37 15 23 − 3.33 25
 Superior temporal cortex R 41 37 − 30 11 − 3.60 15
 Hippocampal cortex L 27 − 22 − 39 3 − 3.22 4
 Postcentral gyrus L 48 − 59 − 12 21 − 3.39 26
 Lingual gyrus
L 18 − 19 − 76 − 3 − 3.54 52
R 18 12 − 71 − 3 − 3.14 27
 Cerebellum
L — − 1 − 52 − 45 − 3.44 27
R — 2 − 52 − 45 − 3.31 21
 PAG — — − 6 − 24 − 7 − 3.89 13
 Brainstem — — 3 − 35 − 40 − 3.09 28
CD > HC
 ACC
L 11 − 3 33 − 3 3.19 11
R 24 2 30 14 3.32 14
 Middle frontal cortex
L 46 − 41 50 18 3.28 20
R 46 36 44 29 3.13 12
 Superior frontal medial cortex
L 10 − 3 64 24 3.16 45
R 10 2 60 24 3.19 69
 Superior parietal cortex L 7 − 18 − 63 57 3.02 17
 Precuneus
L 7 − 1 − 73 49 3.14 15
R 7 2 − 72 48 4.12 30
 Angular gyrus R 39 55 − 63 29 3.26 26
 Middle occipital cortex L 19 − 34 − 81 40 3.87 15
Table 2.  Brain regions exhibiting significant differences in ReHo values between CD patients and 
HCs. P < 0.05, false discovery rate corrected for multiple comparisons. ACC, anterior cingulate cortex; BA, 
Brodmann area; Hem, hemisphere; L, left; MCC, middle cingulate cortex; MNI, Montreal Neurologic Institute; 
PAG, periaqueductal gray; PCC, posterior cingulate cortex; R, right; SMA, supplementary motor area.
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declined self-regulatory functions to various stimuli and disruption of homeostasis. The PCC, mPFC, precuneus, 
angular, amygdale and superior temporal cortex are critical components of the default-mode network (DMN), 
a system that is involved in self-referential processing and shows greater activation during rest than cognitively 
demanding tasks30,31. The detected increase or decrease in ReHo levels in these regions indicate that CD patients 
at resting state may show abnormalities in neuronal spontaneous activities of the DMN, and be dysfunctional 
in detecting internal and external environment, situational memory as well as sustained awareness. In addition, 
the ReHo level in the cortex was significantly increased, while that in the subcortical region was remarkably 
decreased. The coupling of the cortical and subcortical regions was also declined in patients with CD, leading 
to abnormal functional separation in signal transmission between them. These findings indicated that patients 
with CD at resting state likely have abnormalities in synchronization and compatibility in functional activities 
of brain neurons. Consistently, our earlier study13 has demonstrated abnormities in the gray matter structures 
of the insula, ACC, thalamus, amygdala, mPFC, precuneus, superior temporal cortex and other brain areas of 
CD patients. In these patients, brain regions with increased gray matter volumes were mainly located in the 
subcortical regions, cerebellum, and brain stem, while those with decreased gray matter volumes were mainly 
located in the cerebral cortex. These results also indicate decreased coupling between the cortex and subcortical 
Figure 2. Significant differences in ReHo values between CD patients and HCs. (a) The CD patients 
exhibited significantly increased ReHo values compared to the HCs. (b) The CD patients exhibited significantly 
decreased ReHo values compared to the HCs. P < 0.05, false discovery rate was corrected for multiple 
comparisons with age, gender and weight as covariates. ACC, anterior cingulate cortex; Amyg, amygdala; 
dmPFC, dorsomedial prefrontal cortex; HIPP, hippocampal cortex; IFC, inferior frontal cortex; ITC, inferior 
temporal cortex; MCC, middle cingulate cortex; MFC, middle frontal cortex; MTC, middle temporal cortex; 
OC, occipital cortex; PAG, periaqueductal gray; PCC, posterior cingulate cortex; PCUN, precuneus; PPC, 
posterior parietal cortex; S1, primary somatosensory cortex; SFC, superior frontal cortex; SMA, supplementary 
motor area; STC, superior temporal cortex; TP, temporal pole.
Electro-acupuncture 
group (n = 18)
Moxibustion group 
(n = 18)
Statistical 
value P value
Age (years), mean + SD 31.61 ± 5.00 27.50 ± 8.08 t = 1.836 0.08
Gender (male/female), n 13/5 11/7 X2 = 0.500 0.48
Concomitant medication (yes/no), n 16/2 17/1 X2 = 0.364 0.55
Height (cm), mean + SD 170.67 ± 7.99 170.56 ± 6.75 t = 0.045 0.97
Weight (kg), mean + SD 58.08 ± 8.98 56.39 ± 9.65 t = 0.545 0.59
Disease duration (years), mean + SD 6.00 ± 4.58 5.14 ± 3.29 t = 0.648 0.52
CDAI 76.17 ± 40.11 71.78 ± 42.93 t = 0.317 0.75
IBDQ 170.83 ± 22.72 174.78 ± 33.10 t = − 0.417 0.68
Table 3.  Demographic and clinical characteristics of CD patients in each group.
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regions and were consistent with the imaging results in this study. A previous study also showed that CD patients 
have abnormal neural activity in the amygdala, hippocampus, insula, putamen, cerebellar regions when per-
forming stress-evoking tasks, suggesting altered habituation to stress in these patients32. Structurally, CD patients 
were found to exhibit decreased GM volumes in the frontal and the anterior midcingulate cortex17. These find-
ings indicate that there are abnormalities in both structure and functional activities in the brain of CD patients. 
Dysregulation of homeostatic afferent processing network and DMN, as well as declined cortex-subcortical 
region coupling, may be critical hallmarks of local brain activities in CD patients at resting state.
Similarities and differences in the resting-state brain activity between electro-acupuncture 
and moxibustion treatments. After 12 weeks of treatment, the patients in both the EA and Mox groups 
demonstrated significant clinical improvement and the abnormal ReHo levels in multiple brain regions were 
reversed. Although these two methods had similar clinical efficacy and affected several similar brain regions, 
each of them also affected different brain regions. Brain regions that both electro-acupuncture and moxibustion 
treatment significantly reduced the CDAI scores and increased the IBDQ scores in patients with CD, suggesting 
that these methods improve clinical symptoms as well as the quality of life with comparable clinical efficacy. In 
consistent with this result, our earlier study33 also indicated that electro-acupuncture and moxibustion improve 
the score of the Visual Analogue Scale for Irritable Bowel Syndrome (primary outcomes) in irritable bowel syn-
drome patients, indicating beneficial regulatory effects of electro-acupuncture and moxibustion on gastrointes-
tinal functions.
In addition, the abnormal ReHo levels in multiple brain regions were corrected after receiving 
electro-acupuncture and moxibustion treatments. Correlation analysis of efficacy showed that these two treat-
ments resulted in similar activation in certain brain regions and different activation in other regions. Specifically, 
both treatment methods had similar effect on the MCC and TP of subcortical areas, as well as the precentral cor-
tex, postcentral cortex, SMA and dlPFC of the cerebral cortex. Thus, electro-acupuncture and moxibustion may 
regulate functional activities in these brain regions, improve the declined cortex-subcortical region coupling, as 
well as synchronization and compatibility of neuronal spontaneous activities.
Electro-acupuncture and moxibustion also affected different brain regions. Electro-acupuncture significantly 
affected the insula, ACC, thalamus, and HIPP. These brain regions are closely associated with homeostatic afferent 
processing. The insula, ACC, and thalamus are recognized as critical regions of the brain-gut axis interaction, and 
play an important role in processing and regulating pain, emotional visceral sense, as well as homeostasis34,35. 
Moreover, the insula and ACC are related to motivations and feelings associated with changes in body’s physio-
logical condition and with the autonomic response and behaviors that occur in optimal balance restoration29,36. 
The HIPP can regulate immune response via hypothalamus-pituitary gland-adrenal axis and is closely related 
to psychoneuroimmunological regulation37. In this study, the improvements of CDAI scores of CD patients by 
electro-acupuncture were significantly correlated with the changes in ReHo level in these brain regions, indicat-
ing that clinical efficacy of electro-acupuncture may be medicated by regulating homeostatic emotions, immune 
function, and the body’s homeostasis. These findings are consistent with earlier studies on the treatment of func-
tional dyspepsia with electro-acupuncture38.
We found that the mPFC and PCC are closely related to the clinical efficacy of moxibustion. As important 
components of the DMN, mPFC and PCC are involved in self-referencing processes30,39. The DMN has been 
shown to be deactivated during several different types of meditation, such as concentration, loving-kindness, and 
during the state of diminished awareness in experienced meditators40. A recent study indicated that acupuncture 
stimulation can deactivate the DMN, which may be derived from enhanced bodily attention to certain parts of 
the body, suggesting that enhanced bodily attention around the acupoints is significant in the brain’s response to 
acupuncture stimulation41. In this study, we found that the reduced CDAI score due to moxibustion treatment 
was significantly correlated with ReHo level changes in DMN including mPFC and PCC, indicating that the clin-
ical efficacy of moxibustion may lie in its regulation of DMN and enhanced bodily attention. Patients receiving 
moxibustion usually experience gratification and warmth, and this stimulation is regarded as a critical factor 
of its efficacy42,43. Therefore, we propose that moxibustion regulates the DMN, particularly mPFC and PCC, by 
Items Electro-acupuncture group (n = 16) Moxibustion group (n = 18)
CDAI
 Baseline, mean ± SD 76.17 ± 40.11 71.78 ± 42.93
 Post-treatment, mean ± SD 48.06 ± 30.50* 40.56 ± 28.53*
 Changes from baseline to post-treatment − 28.11 ± 29.81 − 31.22 ± 26.14
 Statistical value 0.333
 P value 0.74
IBDQ
 Baseline, mean ± SD 170.83 ± 22.72 174.78 ± 33.10
 Post-treatment, mean ± SD 188.11 ± 19.54* 190.78 ± 21.81*
 Changes from baseline to post-treatment 17.28 ± 19.50 16.00 ± 18.13
 Statistical value 0.204
 P value 0.84
Table 4.  Clinical outcome measurements. Compared with baseline, *P < 0.01.
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making the CD patients more aware of their bodies and feelings in the abdomen. In our earlier studies, we also 
found that moxibustion suppressed abnormal PFC activation in patients with chronic visceral pain44. Therefore, 
we believe that the effect of moxibustion on CD is partially mediated by its regulation of DMN and enhancing 
bodily attention on the abdomen region.
Electro-acupuncture group Moxibustion group
Regions Hem BA
MNI
t value Voxels BA
MNI
t value Voxelsx y z x y z
Inferior frontal cortex
L 45 − 46 33 12 3.35 27 48 − 55 12 6 3.58 31
R 48 56 16 12 3.31 21 48 53 12 9 3.14 20
Orbital frontal cortex
L 11 − 21 36 − 21 − 3.90 12 — — — — — —
R 47 34 42 − 9 − 3.39 12 11 10 34 − 13 − 3.69 15
Middle frontal cortex R 46 37 33 39 − 3.59 20 46 45 28 39 − 4.48 17
Superior medial frontal cortex L — — — — — — 8 − 1 27 63 − 3.47 12
Precentral cortex
L 6 − 36 − 10 45 3.89 23 — — — — — —
R 6 28 − 21 63 3.82 20 6 48 4 36 3.39 18
Postcentral cortex R 3 28 − 36 63 5.07 30 3 21 − 36 63 3.35 22
Paracentral lobule
L 4 − 12 − 28 56 4.87 34 6 − 12 − 17 66 3.12 17
R 5 9 − 29 51 3.14 11 — — — — — —
Superior parietal cortex L 7 − 26 − 60 69 − 3.85 9 — — — — — —
Angular cortex L 39 − 49 − 62 33 − 4.14 7 39 − 39 − 57 39 3.69 10
SMA
L — — — — — — 8 − 6 21 56 3.68 12
R 3 28 − 36 61 4.68 14 6 9 14 51 3.47 17
Inferior temporal cortex
L 21 − 55 − 3 − 28 − 3.94 11 20 − 41 3 − 30 − 3.73 7
R 20 57 − 12 − 36 − 3.47 10 — — — — — —
Middle temporal cortex
L — — — — — — 21 − 55 10 − 21 − 3.30 14
R — — — — — — 37 57 − 57 3 − 3.67 17
Temporal pole L 38 − 52 23 − 18 − 3.40 10 21 − 45 3 − 18 − 3.43 9
Superior temporal cortex
L 21 − 45 − 33 6 4.77 26 — — — — — —
R 38 57 3 − 3 3.64 35 — — — — — —
Fusiform cortex L — — — — — — 20 − 38 − 22 − 24 3.36 10
Middle occipital cortex
L 17 − 25 − 100 0 − 3.30 21 19 − 27 − 85 27 3.01 11
R 7 33 − 60 36 − 3.71 18 19 31 − 79 36 3.16 17
Cuneus L 18 − 1 − 81 33 − 3.62 15 — — — — — —
Lingual cortex
L — — — — — — 17 1 − 77 0 − 3.25 12
R 37 21 − 44 − 6 3.20 15 17 16 − 57 5 − 3.08 14
Insula R 48 42 12 − 3 4.57 29 48 37 22 6 3.80 11
ACC
L 32 − 4 38 6 − 3.10 21 — — — — — —
R 32 6 42 8 − 5.22 27 — — — — — —
MCC
L 24 − 6 − 11 39 5.18 17 24 − 6 12 39 3.80 32
R 24 6 4 42 4.29 11 23 6 − 24 42 4.49 21
PCC L — — — — — — 23 − 6 − 36 34 3.46 34
Thalamus
L — − 11 − 12 2 3.95 45 — — — — — —
R — 22 − 24 0 3.13 21 — — — — — —
Parahippocampus/Hippocampus L 20 − 24 − 21 − 12 3.38 10 — — — — — —
Caudate nucleus R — 15 21 3 − 4.82 13 25 7 13 9 − 3.48 11
Pallidum
L — − 21 − 6 − 3 5.21 17 — − 13 8 0 4.23 11
R — — — — — — — 16 6 0 3.37 23
Putamen
L — — — — — — — − 21 8 0 4.22 12
R — 24 12 6 6.29 13 — 29 6 3 3.98 11
Cerebellum
L — − 28 − 66 − 21 3.64 10 — − 30 − 59 − 54 3.47 19
R — — — — — — — 35 − 71 − 20 4.01 29
Brainstem — — 0 − 36 − 36 3.71 11 — 3 − 37 − 39 4.18 21
Table 5.  Brain regions with significant differences in ReHo values in CD patients after electro-acupuncture 
and moxibustion treatment (post-treatment minus the baseline). P < 0.05, false discovery rate corrected for 
multiple comparisons. ACC, anterior cingulate cortex; BA, Brodmann area; Hem, hemisphere; L, left; MCC, 
middle cingulate cortex; MNI, Montreal Neurologic Institute; PCC, posterior cingulate cortex; R, right; SMA, 
supplementary motor area.
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One limitation of this study is the lack of a placebo-controlled group. Our placebo-controlled protocol was 
denied by the Institutional Review Board due to likely progression and recurrence of CD, even in patients in 
remission. Therefore, we could not rule out non-specific effects of electro-acupuncture and moxibustion. 
However, this issue may be addressed in future research, such as by reducing the period of electro-acupuncture 
and moxibustion interventions.
In conclusion, we compared the effects of electro-acupuncture and moxibustion treatments on brain responses 
in CD patients. We found that both treatments were effective in normalizing the decreased cortical-subcortical 
coupling of the brain. Our data suggest that regulation of the homeostatic afferent processing network, includ-
ing the insula, ACC, thalamus, and HIPP, may be the primary pattern of brain response to electro-acupuncture 
treatment. Regulation of the DMN, including mPFC and PCC, may be the primary pattern of brain response to 
moxibustion treatment.
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